Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy.
Frontiers in oncology（2023）
摘要
The IRGs signature could act as a biomarker and provide a momentous reference for individual therapy of TNBC.
更多查看译文
关键词
triple negative breast cancer,breast cancer,immunotherapy,response-related
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要